Status:

RECRUITING

Diagnostic Innovations for Pediatric Tuberculosis in Bolivia

Lead Sponsor:

Tulane University

Collaborating Sponsors:

Asociacion Benefica Prisma

Universidad Peruana Cayetano Heredia

Conditions:

Tuberculosis

Eligibility:

All Genders

2-14 years

Brief Summary

Pediatric tuberculosis (TB) continues to pose diagnostic challenges in low- and middle-income countries with high rates of TB disease, due to the well-described impact of paucibacillary disease in chi...

Detailed Description

Pediatric subject populations, enrollment, and follow-up: During the first two years of the study, a "test population" will be recruited for 18 months to establish quantitative cfDNA standards and ran...

Eligibility Criteria

Inclusion

  • Children presenting for evaluation for symptomatic respiratory disease and suspicion of tuberculosis will be eligible for enrollment (inclusion criteria based on Bolivian Ministry of Health guidelines for suspect cases of tuberculosis in children

Exclusion

  • prior treatment for TB within the past year,
  • current treatment for prevention of TB,
  • weight \< 2.5 kg., or
  • clinical instability,
  • positive COVID-19 diagnostic test

Key Trial Info

Start Date :

April 15 2024

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

October 1 2028

Estimated Enrollment :

1220 Patients enrolled

Trial Details

Trial ID

NCT06113861

Start Date

April 15 2024

End Date

October 1 2028

Last Update

September 5 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hospital de Ninos "Mario Ortiz Suarez"

Santa Cruz, Bolivia